Kapil Dhingra is of LAVA Therapeutics NV. Currently has a direct ownership of 0 shares of LVTX, which is worth approximately $0. The most recent transaction as insider was on Nov 13, 2025, when has been sold 30,000 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Kapil Dhingra Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 13 2025
SELL
Sale (or disposition) back to the issuer
-
30,000 Reduced 100.0%
0 Common Shares

Also insider at

REPL
Replimune Group, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
FPRX
FIVE PRIME THERAPEUTICS, INC.
CRGX
CARGO Therapeutics, Inc.
KD

Kapil Dhingra

Woburn, MA

Track Institutional and Insider Activities on LVTX

Follow LAVA Therapeutics NV and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LVTX shares.

Notify only if

Insider Trading

Get notified when an Lava Therapeutics Nv insider buys or sells LVTX shares.

Notify only if

News

Receive news related to LAVA Therapeutics NV

Track Activities on LVTX